You predicted the current shareprice back in June so stop moaning and wait for the next RNS... Quote from you in June below, nearly spot on: "Hello David....imo I don't think the Zema approval RNS will be the RNS that shoots the lights out here. If I was to take a guess, I would say north of 2pps only at this stage. As we have experienced here, steady progress to get to this stage has only resulted in BMR reaching near all time lows of late. The Zema approval RNS will of course move the sp up, but by how much is anyone's guess. It will be the RNS' that follow approval giving path to production timescales and how it will all be financed that will be the game changer here. Only then I believe, will we see true value reflected in the SP imo. As always, bwtfdik....lol"
Yes there is some short term noise, although is justified to a certain extent, we have been waiting for approval for last 12 months and the result has been little or no impact. Nobody is disputing the potential here, but the sp and its current status is, particularly after such instrumental news has been confirmed.
It is amazing how many new names pop up bashing the company and "lack of rise" controlled completely by Novum. There are games afoot, dark pools, nominee accounts hiding who owns what, who is hovering up shares and who the high networth individual is who is more than happy to keep ploughing money into BMR with all of the information we don't have. DavidDavidson - I bet you are selling and really advertising the fact to help you sell at the lowest price you can...not. You would be pumping and dumping with a false rumour if you really were selling.
We all know that Masoud has friends with money and my betting is they are the funders who know BMR's business' so well and operate through Novum to buy shares as cheaply as possible for when this turns to showing it's first year turnover and profits at which point a true valuation can be made with huge upside from todays price.
Novum are always in control and lead the shareprice in the direction that suits them and their anonymous high net worth individual investor who clearly believes in BMR and believes in Masouds abilities. Novum are also on Park Lane near BMR HQ. If you look at the Novum website this I believe is their focus and under market making they say they are "client orientated" and "achieve the most effective trading execution" for their clients (Masoud and his high networth friends):
We focus on building a long term relationship between the owners and managers of growth businesses, both private and publicly quoted, and the providers of capital. Our range of capital providers, whilst including a number of the traditional long only funds, focuses on high networth and strategic investors. We provide truly independent corporate finance advice and we are happy to work alongside other investment banks and nominated advisers. We aim to provide strategic advice across the broad range of corporate finance activities to enable management teams to build and realise equity value for themselves and their investors. Our service includes: •Strategic advice on fundraisings for quoted and private companies •Acting as nominated broker to AIM quoted companies; •M&A, including significant experience with takeovers of public companies and the •regulatory requirements of the Panel on Takeovers and Mergers •Transaction management and execution.
Novum Securities is an independent stockbroking house focused on the UK securities market. Based on Park Lane, we specialise in providing discrete and highly professional sales and execution to institutional and high net worth clients alongside market making and corporate finance to quoted and private companies.
We provide an agency broking and execution service to institutions and high net worth individuals. With a focus on discretion and integrity coupled with the firm’s independence our team is able to provide a conflict free service to our clients with complete anonymity.
We offer trading in CFDs, Spread Betting, Debt and Equities which where appropriate is facilitated by our team of market makers and relationships with third party providers.
We offer a highly competitive and client-orientated market-making in a broad range of smaller UK companies, listed on either the Official List or AIM. We have registered as a Retail Service Provider and the team has established links with the retail broking community. Our experienced team of market makers understand the issues of liquidity and pricing prevalent
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.